In situ Synthesis of Amorphous Fluorinated Calcium Phosphate Nanoparticles via a Dual-Component Hydrogel for Biomimetic Tooth Remineralization
Abstract
Objective: To report the in situ synthesis of amorphous fluorinated calcium phosphate (AFCP) nanoparticles within a dual-component hydrogel and evaluate their efficacy for enamel remineralization and dentinal tubules (DTs) occlusion.
Materials and methods: The AFCP hydrogel was constructed using hydroxypropyl methylcellulose (HPMC) and carboxymethyl chitosan (CMC) to stabilize calcium, phosphate, and fluoride ions in a metastable amorphous state. Physicochemical characterization was performed by FTIR, XRD, TEM, and SEM-EDX. Biocompatibility was assessed via CCK-8 assays and oral mucosal irritation test. Demineralized enamel and dentin specimens (n=8) were treated with deionized water, fluoride (NaF, 2000 ppm F), 10% CPP-ACP with 900 ppm F (GC Tooth Mousse Plus, Japan), or AFCP hydrogel, and immersed in artificial saliva for 7 days. Remineralization was evaluated by SEM, XRD, and nanoindentation, followed by in vivo validation in a rabbit model.
Results: The hydrogel generated AFCP nanoparticles (30-80 nm) that remained amorphous in artificial saliva for over 2 hours before crystallizing into hydroxyapatite. The hydrogel exhibited negligible cytotoxicity and no oral mucosal irritation. After 7 days, the AFCP hydrogel induced dense mineral deposition that completely occluded exposed DTs and formed a ~32 µm remineralized layer on acid-etched enamel, substantially outperforming fluoride and CPP-ACP + NaF. XRD confirmed the newly formed mineral as hydroxyapatite-like. Treatment…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.